Fundies. English
Segment disclosures
Company overviewAscent Industries Co.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
43 dimension combinations 237 retained observations 38 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · All Other Countries · Specialty Chemicals Segment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=acnt:AllOtherCountriesMember;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 9000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
Operating Segments · AR · Specialty Chemicals Segment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:AR;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 47000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
Operating Segments · BR · Specialty Chemicals Segment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:BR;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 11000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
Operating Segments · BS · Specialty Chemicals Segment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:BS;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 37000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
Operating Segments · CA · Specialty Chemicals Segment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:CA;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 182000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 785000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 224000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1750000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
Operating Segments · CO · Specialty Chemicals Segment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:CO;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 111000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 627000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 137000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
Operating Segments · CR · Specialty Chemicals Segment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:CR;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 49000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 266000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 29000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 194000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
Operating Segments · GT · Specialty Chemicals Segment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:GT;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 53000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 23000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 22000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
Operating Segments · HN · Specialty Chemicals Segment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:HN;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 172000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 711000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 270000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1212000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
Operating Segments · JP · Specialty Chemicals Segment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:JP;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 90000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
Operating Segments · MX · Specialty Chemicals Segment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:MX;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 3000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1186000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 472000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1880000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
Operating Segments · NL · Specialty Chemicals Segment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:NL;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 27000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 597000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 34000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
Operating Segments · SG · Specialty Chemicals Segment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:SG;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 44000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 44000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 44000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
Operating Segments · TH · Specialty Chemicals Segment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:TH;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | -3000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 20000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 2000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
Operating Segments · TW · Specialty Chemicals Segment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:TW;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 31000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 30000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
Operating Segments · US · Specialty Chemicals Segment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 18830000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 70495000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 16644000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 75564000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
Operating Segments · Specialty Chemicals
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 17835000 | USD | 2025-05-12 · 21:15:41.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 80764000 | USD | 2025-03-04 · 22:14:08.000Z | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 20296000 | USD | 2025-05-12 · 21:15:41.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 83616000 | USD | 2025-03-04 · 22:14:08.000Z | Open filing evidence |
Operating Segments · Specialty Chemicals Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 25667000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 45083000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 19415000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 74942000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 19697000 | USD | 2025-11-04 · 22:13:10.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 56183000 | USD | 2025-11-04 · 22:13:10.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 18652000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 36486000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 17835000 | USD | 2026-05-06 · 21:08:28.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 80763000 | USD | 2026-03-03 · 22:09:08.000Z | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 20878000 | USD | 2025-11-04 · 22:13:10.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 62642000 | USD | 2025-11-04 · 22:13:10.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 21468000 | USD | 2025-08-06 · 21:10:50.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 41764000 | USD | 2025-08-06 · 21:10:50.000Z | Open filing evidence |
Operating Segments · Tubular Products
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=acnt:TubularProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 6897000 | USD | 2025-05-12 · 21:15:41.000Z | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 97108000 | USD | 2025-03-04 · 22:14:08.000Z | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 7656000 | USD | 2025-05-12 · 21:15:41.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 109513000 | USD | 2025-03-04 · 22:14:08.000Z | Open filing evidence |
Operating Segments · Metals Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=synl:MetalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-03-31 | 60664000 | USD | 2020-05-05 · 20:05:19.000Z | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 251078000 | USD | 2020-03-06 · 20:36:15.000Z | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 60121145 | USD | 2019-11-12 · 17:15:54.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 195727598 | USD | 2019-11-12 · 17:15:54.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 64503373 | USD | 2019-08-13 · 17:16:22.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 135606452 | USD | 2019-08-13 · 17:16:22.000Z | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 71103000 Restated | USD | 2020-05-05 · 20:05:19.000Z | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 222242000 Restated | USD | 2020-03-06 · 20:36:15.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 61024373 | USD | 2019-11-12 · 17:15:54.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 162891099 | USD | 2019-11-12 · 17:15:54.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 56374479 | USD | 2019-08-13 · 17:16:22.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 101866726 | USD | 2019-08-13 · 17:16:22.000Z | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 45492247 | USD | 2019-04-30 · 18:44:13.000Z | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 152957000 Restated | USD | 2020-03-06 · 20:36:15.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 43022833 | USD | 2018-11-06 · 21:45:01.000Z | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 111821115 | USD | 2018-11-06 · 21:45:01.000Z | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 39088322 | USD | 2018-08-07 · 21:09:42.000Z | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 68798282 | USD | 2018-08-07 · 21:09:42.000Z | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 90214537 | USD | 2019-03-18 · 18:17:01.000Z | Open filing evidence |
Operating Segments · Specialty Chemicals Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=synl:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-03-31 | 14033000 | USD | 2020-05-05 · 20:05:19.000Z | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 54090000 | USD | 2020-03-06 · 20:36:15.000Z | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 13518766 | USD | 2019-11-12 · 17:15:54.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 41494121 | USD | 2019-11-12 · 17:15:54.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 14274603 | USD | 2019-08-13 · 17:16:22.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 27975356 | USD | 2019-08-13 · 17:16:22.000Z | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 13701000 Restated | USD | 2020-05-05 · 20:05:19.000Z | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 58599000 Restated | USD | 2020-03-06 · 20:36:15.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 16768505 | USD | 2019-11-12 · 17:15:54.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 45276144 | USD | 2019-11-12 · 17:15:54.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 15519284 | USD | 2019-08-13 · 17:16:22.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 28507639 | USD | 2019-08-13 · 17:16:22.000Z | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 12988355 | USD | 2019-04-30 · 18:44:13.000Z | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 48191000 Restated | USD | 2020-03-06 · 20:36:15.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 11573091 | USD | 2018-11-06 · 21:45:01.000Z | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 36489433 | USD | 2018-11-06 · 21:45:01.000Z | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 12422723 | USD | 2018-08-07 · 21:09:42.000Z | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 24916342 | USD | 2018-08-07 · 21:09:42.000Z | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 48351245 | USD | 2019-03-18 · 18:17:01.000Z | Open filing evidence |
All Other Countries · Specialty Chemicals Segment · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=acnt:AllOtherCountriesMember;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 154000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 271000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 143000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 168000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
CA · Specialty Chemicals Segment · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=country:CA;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 209000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 391000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 200000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 424000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
CO · Specialty Chemicals Segment · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=country:CO;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 151000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 263000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 166000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 303000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
CR · Specialty Chemicals Segment · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=country:CR;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 144000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 172000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
HN · Specialty Chemicals Segment · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=country:HN;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 278000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 450000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 270000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
MX · Specialty Chemicals Segment · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=country:MX;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 402000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 405000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 213000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 686000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
NL · Specialty Chemicals Segment · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=country:NL;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 336000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 370000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
US · Operating Segments · Specialty Chemicals
Statement Geographical · Consolidation Items · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=country:US;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 75565000 | USD | 2025-03-04 · 22:14:08.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 79498000 | USD | 2025-03-04 · 22:14:08.000Z | Open filing evidence |
US · Operating Segments · Tubular Products
Statement Geographical · Consolidation Items · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=country:US;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=acnt:TubularProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 95264000 | USD | 2025-03-04 · 22:14:08.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 108693000 | USD | 2025-03-04 · 22:14:08.000Z | Open filing evidence |
US · Specialty Chemicals Segment · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 24473000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 43303000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 17450000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 34093000 | USD | 2026-08-04 · 21:18:21.000Z | Open filing evidence |
Non Us · Operating Segments · Specialty Chemicals
Statement Geographical · Consolidation Items · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=us-gaap:NonUsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 5199000 | USD | 2025-03-04 · 22:14:08.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 4118000 | USD | 2025-03-04 · 22:14:08.000Z | Open filing evidence |
Non Us · Operating Segments · Tubular Products
Statement Geographical · Consolidation Items · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=us-gaap:NonUsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=acnt:TubularProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 1844000 | USD | 2025-03-04 · 22:14:08.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 820000 | USD | 2025-03-04 · 22:14:08.000Z | Open filing evidence |
Specialty Chemicals
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 107542000 | USD | 2023-03-31 · 20:16:30.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 67477000 | USD | 2023-03-31 · 20:16:30.000Z | Open filing evidence |
Specialty Chemicals · Segment Continuing Operations
Statement Business Segments · Statement Operating Activities Segment
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsMember;us-gaap:StatementOperatingActivitiesSegmentAxis=us-gaap:SegmentContinuingOperationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 83616000 | USD | 2024-04-01 · 20:51:04.000Z | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 107542000 | USD | 2024-04-01 · 20:51:04.000Z | Open filing evidence |
Specialty Chemicals Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acnt:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 20878000 | USD | 2024-11-12 · 22:08:52.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 62642000 | USD | 2024-11-12 · 22:08:52.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 21468000 | USD | 2024-08-06 · 21:11:04.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 41764000 | USD | 2024-08-06 · 21:11:04.000Z | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 20296000 | USD | 2024-05-08 · 21:07:51.000Z | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 20052000 | USD | 2024-11-12 · 22:08:52.000Z | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 65165000 Restated | USD | 2024-11-12 · 22:08:52.000Z | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 21363000 | USD | 2024-08-06 · 21:11:04.000Z | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 45112000 | USD | 2024-08-06 · 21:11:04.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 23749000 | USD | 2024-05-08 · 21:07:51.000Z | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 27328000 | USD | 2023-11-08 · 22:24:16.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 84070000 | USD | 2023-11-08 · 22:24:16.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 29020000 | USD | 2023-08-08 · 21:16:36.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 56741000 | USD | 2023-08-08 · 21:16:36.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 27721000 | USD | 2023-05-09 · 21:17:33.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 16055000 | USD | 2022-11-08 · 22:21:40.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 45609000 | USD | 2022-11-08 · 22:21:40.000Z | Open filing evidence |
Tubular Products
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acnt:TubularProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 306605000 | USD | 2023-03-31 · 20:16:30.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 267238000 | USD | 2023-03-31 · 20:16:30.000Z | Open filing evidence |
Tubular Products · Segment Continuing Operations
Statement Business Segments · Statement Operating Activities Segment
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acnt:TubularProductsMember;us-gaap:StatementOperatingActivitiesSegmentAxis=us-gaap:SegmentContinuingOperationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 109513000 | USD | 2024-04-01 · 20:51:04.000Z | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 154040000 | USD | 2024-04-01 · 20:51:04.000Z | Open filing evidence |
Tubular Products Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acnt:TubularProductsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 22023000 | USD | 2024-11-12 · 22:08:52.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 74559000 | USD | 2024-11-12 · 22:08:52.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 28721000 | USD | 2024-08-06 · 21:11:04.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 52536000 | USD | 2024-08-06 · 21:11:04.000Z | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 23814000 | USD | 2024-05-08 · 21:07:51.000Z | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 26695000 Restated | USD | 2024-11-12 · 22:08:52.000Z | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 86748000 Restated | USD | 2024-11-12 · 22:08:52.000Z | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 28992000 Restated | USD | 2024-08-06 · 21:11:04.000Z | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 60053000 Restated | USD | 2024-08-06 · 21:11:04.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 31061000 Restated | USD | 2024-05-08 · 21:07:51.000Z | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 50606000 Restated | USD | 2023-11-08 · 22:24:16.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 162059000 Restated | USD | 2023-11-08 · 22:24:16.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 55580000 | USD | 2023-08-08 · 21:16:36.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 111454000 | USD | 2023-08-08 · 21:16:36.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 88383000 | USD | 2023-05-09 · 21:17:33.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 70127000 | USD | 2022-11-08 · 22:21:40.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 193438000 | USD | 2022-11-08 · 22:21:40.000Z | Open filing evidence |
Metals Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=synl:MetalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 87182000 | USD | 2022-08-09 · 21:14:51.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 175679000 | USD | 2022-08-09 · 21:14:51.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 88497000 | USD | 2022-05-10 · 21:26:35.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 267238000 | USD | 2022-03-29 · 21:13:15.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 70127000 | USD | 2021-11-09 · 22:26:11.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 193438000 | USD | 2021-11-09 · 22:26:11.000Z | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 68097000 | USD | 2022-08-09 · 21:14:51.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 123311000 | USD | 2022-08-09 · 21:14:51.000Z | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 55213000 | USD | 2022-05-10 · 21:26:35.000Z | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 204459000 | USD | 2022-03-29 · 21:13:15.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 47079000 | USD | 2021-11-09 · 22:26:11.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 159761000 | USD | 2021-11-09 · 22:26:11.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 52018000 | USD | 2021-08-09 · 20:47:25.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 112681000 | USD | 2021-08-09 · 20:47:25.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 60664000 | USD | 2021-05-10 · 20:48:09.000Z | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 251078000 | USD | 2021-03-09 · 21:26:58.000Z | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 60121000 | USD | 2020-11-09 · 20:37:32.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 195728000 | USD | 2020-11-09 · 20:37:32.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 64503000 | USD | 2020-09-03 · 20:16:16.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 135607000 | USD | 2020-09-03 · 20:16:16.000Z | Open filing evidence |
Specialty Chemicals Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=synl:SpecialtyChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 29020000 | USD | 2022-08-09 · 21:14:51.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 56741000 | USD | 2022-08-09 · 21:14:51.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 27721000 | USD | 2022-05-10 · 21:26:35.000Z | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 67477000 | USD | 2022-03-29 · 21:13:15.000Z | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 16055000 | USD | 2021-11-09 · 22:26:11.000Z | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 45609000 | USD | 2021-11-09 · 22:26:11.000Z | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 14990000 | USD | 2022-08-09 · 21:14:51.000Z | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 29554000 | USD | 2022-08-09 · 21:14:51.000Z | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 14565000 | USD | 2022-05-10 · 21:26:35.000Z | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 51541000 | USD | 2022-03-29 · 21:13:15.000Z | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 12187000 | USD | 2021-11-09 · 22:26:11.000Z | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 40338000 | USD | 2021-11-09 · 22:26:11.000Z | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 14118000 | USD | 2021-08-09 · 20:47:25.000Z | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 28152000 | USD | 2021-08-09 · 20:47:25.000Z | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 14033000 | USD | 2021-05-10 · 20:48:09.000Z | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 54090000 | USD | 2021-03-09 · 21:26:58.000Z | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 13519000 | USD | 2020-11-09 · 20:37:32.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 41494000 | USD | 2020-11-09 · 20:37:32.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 14275000 | USD | 2020-09-03 · 20:16:16.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 27975000 | USD | 2020-09-03 · 20:16:16.000Z | Open filing evidence |
All Other Segments
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 0 | USD | 2024-11-12 · 22:08:52.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 2024-11-12 · 22:08:52.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 2024-08-06 · 21:11:04.000Z | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 2024-08-06 · 21:11:04.000Z | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 2024-05-08 · 21:07:51.000Z | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 2024-11-12 · 22:08:52.000Z | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 50000 | USD | 2024-11-12 · 22:08:52.000Z | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 2024-08-06 · 21:11:04.000Z | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 50000 | USD | 2024-08-06 · 21:11:04.000Z | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 50000 | USD | 2024-05-08 · 21:07:51.000Z | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 287000 | USD | 2023-11-08 · 22:24:16.000Z | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 401000 | USD | 2023-11-08 · 22:24:16.000Z | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 0 | USD | 2023-08-08 · 21:16:36.000Z | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 114000 | USD | 2023-08-08 · 21:16:36.000Z | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 114000 | USD | 2023-05-09 · 21:17:33.000Z | Open filing evidence |
All Other Segments · Segment Continuing Operations
Statement Business Segments · Statement Operating Activities Segment
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;us-gaap:StatementOperatingActivitiesSegmentAxis=us-gaap:SegmentContinuingOperationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 50000 | USD | 2024-04-01 · 20:51:04.000Z | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 411000 | USD | 2024-04-01 · 20:51:04.000Z | Open filing evidence |